{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T17:52:51Z","timestamp":1790358771570,"version":"4.1.0"},"reference-count":88,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100002923","name":"Consejo Nacional de Investigaciones Cient\u00edficas y T\u00e9cnicas","doi-asserted-by":"publisher","award":["PIP 2022\\u20132024"],"award-info":[{"award-number":["PIP 2022\\u20132024"]}],"id":[{"id":"10.13039\/501100002923","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002923","name":"Consejo Nacional de Investigaciones Cient\u00edficas y T\u00e9cnicas","doi-asserted-by":"publisher","award":["1547\/16"],"award-info":[{"award-number":["1547\/16"]}],"id":[{"id":"10.13039\/501100002923","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003074","name":"Agencia Nacional de Promoci\u00f3n Cient\u00edfica y Tecnol\u00f3gica","doi-asserted-by":"publisher","award":["PICT-2015-2175"],"award-info":[{"award-number":["PICT-2015-2175"]}],"id":[{"id":"10.13039\/501100003074","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003074","name":"Agencia Nacional de Promoci\u00f3n Cient\u00edfica y Tecnol\u00f3gica","doi-asserted-by":"publisher","award":["PICT-2020-0512"],"award-info":[{"award-number":["PICT-2020-0512"]}],"id":[{"id":"10.13039\/501100003074","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.bbadis.2025.167826","type":"journal-article","created":{"date-parts":[[2025,4,6]],"date-time":"2025-04-06T09:47:50Z","timestamp":1743932870000},"page":"167826","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Therapeutic potential of GNRHR analogs and SRC\/FAK inhibitors to counteract tumor growth and metastasis in breast cancer"],"prefix":"10.1016","volume":"1871","author":[{"given":"Joselina Magali","family":"Mondaca","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan Manuel Fernandez","family":"Mu\u00f1oz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gustavo Adolfo","family":"Barraza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fiorella","family":"Vanderhoeven","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anal\u00eda Lourdes","family":"Redondo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina In\u00e9s","family":"Flamini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angel Matias","family":"Sanchez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbadis.2025.167826_bb0005","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/jbiol67","article-title":"Reasons for breast cancer heterogeneity","volume":"7","author":"Bertucci","year":"2008","journal-title":"J. Biol."},{"key":"10.1016\/j.bbadis.2025.167826_bb0010","doi-asserted-by":"crossref","first-page":"209","DOI":"10.3322\/caac.21660","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.bbadis.2025.167826_bb0015","doi-asserted-by":"crossref","first-page":"981","DOI":"10.3892\/or_00000525","article-title":"Human gonadotropin-releasing hormone receptor-activated cellular functions and signaling pathways in extra-pituitary tissues and cancer cells (review)","volume":"22","author":"Aguilar-Rojas","year":"2009","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.bbadis.2025.167826_bb0020","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1093\/humupd\/dml020","article-title":"Ovarian feedback, mechanism of action and possible clinical implications","volume":"12","author":"Messinis","year":"2006","journal-title":"Hum. Reprod. Update"},{"key":"10.1016\/j.bbadis.2025.167826_bb0025","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1023\/A:1023351819956","article-title":"A novel approach of targeted ablation of mammary carcinoma cells through luteinizing hormone receptors using Hecate-CGbeta conjugate","volume":"79","author":"Bodek","year":"2003","journal-title":"Breast Cancer Res. Treat."},{"key":"10.1016\/j.bbadis.2025.167826_bb0030","doi-asserted-by":"crossref","DOI":"10.3390\/ijms242115965","article-title":"Gonadotropin-releasing hormone receptor (GnRHR) and hypogonadotropic hypogonadism","volume":"24","author":"Fanis","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbadis.2025.167826_bb0035","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1210\/er.2012-1014","article-title":"GnRH receptors in cancer: from cell biology to novel targeted therapeutic strategies","volume":"33","author":"Limonta","year":"2012","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.bbadis.2025.167826_bb0040","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1002\/cncr.11294","article-title":"Luteinizing hormone receptor status and clinical, pathologic, and prognostic features in patients with breast carcinomas","volume":"97","author":"Meduri","year":"2003","journal-title":"Cancer"},{"key":"10.1016\/j.bbadis.2025.167826_bb0045","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1056\/NEJMoa1001283","article-title":"Expression of follicle-stimulating hormone receptor in tumor blood vessels","volume":"363","author":"Radu","year":"2010","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bbadis.2025.167826_bb0050","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.mce.2016.08.009","article-title":"LH and FSH promote migration and invasion properties of a breast cancer cell line through regulatory actions on the actin cytoskeleton","volume":"437","author":"Sanchez","year":"2016","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.bbadis.2025.167826_bb0055","doi-asserted-by":"crossref","first-page":"239","DOI":"10.3389\/fendo.2018.00239","article-title":"Regulatory actions of LH and follicle-stimulating hormone on breast cancer cells and mammary tumors in rats","volume":"9","author":"Sanchez","year":"2018","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.bbadis.2025.167826_bb0060","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2023.1143261","article-title":"Conventional and new proposals of GnRH therapy for ovarian, breast, and prostatic cancers","volume":"14","author":"Garrido","year":"2023","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.bbadis.2025.167826_bb0065","doi-asserted-by":"crossref","first-page":"187","DOI":"10.3389\/fendo.2017.00187","article-title":"The role of gonadotropin-releasing hormone in cancer cell proliferation and metastasis","volume":"8","author":"Grundker","year":"2017","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.bbadis.2025.167826_bb0070","doi-asserted-by":"crossref","first-page":"930","DOI":"10.2165\/00003495-199448060-00008","article-title":"Leuprorelin. A review of its pharmacology and therapeutic use in prostatic cancer, endometriosis and other sex hormone-related disorders","volume":"48","author":"Plosker","year":"1994","journal-title":"Drugs"},{"key":"10.1016\/j.bbadis.2025.167826_bb0075","article-title":"Degarelix improves suppression of ovarian function","volume":"20","author":"Gourd","year":"2019","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.bbadis.2025.167826_bb0080","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0120670","article-title":"In search of the molecular mechanisms mediating the inhibitory effect of the GnRH antagonist degarelix on human prostate cell growth","volume":"10","author":"Sakai","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.bbadis.2025.167826_bb0085","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1111\/joim.12084","article-title":"Breast cancer as a systemic disease: a view of metastasis","volume":"274","author":"Redig","year":"2013","journal-title":"J. Intern. Med."},{"key":"10.1016\/j.bbadis.2025.167826_bb0090","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1038\/nrc1670","article-title":"Breast cancer metastasis: markers and models","volume":"5","author":"Weigelt","year":"2005","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.bbadis.2025.167826_bb0095","doi-asserted-by":"crossref","first-page":"6525","DOI":"10.1007\/s11033-021-06635-z","article-title":"Matrix metalloproteinase contribution in management of cancer proliferation, metastasis and drug targeting","volume":"48","author":"Abdel-Hamid","year":"2021","journal-title":"Mol. Biol. Rep."},{"key":"10.1016\/j.bbadis.2025.167826_bb0100","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.critrevonc.2019.02.010","article-title":"Matrix metalloproteinases participation in the metastatic process and their diagnostic and therapeutic applications in cancer","volume":"137","author":"Gonzalez-Avila","year":"2019","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"10.1016\/j.bbadis.2025.167826_bb0105","doi-asserted-by":"crossref","DOI":"10.3390\/molecules26144250","article-title":"Drug discovery targeting focal adhesion kinase (FAK) as a promising cancer therapy","volume":"26","author":"Pang","year":"2021","journal-title":"Molecules"},{"key":"10.1016\/j.bbadis.2025.167826_bb0110","doi-asserted-by":"crossref","first-page":"83","DOI":"10.2147\/OTT.S6909","article-title":"The dual kinase complex FAK-Src as a promising therapeutic target in cancer","volume":"3","author":"Bolos","year":"2010","journal-title":"Onco. Targets Ther."},{"key":"10.1016\/j.bbadis.2025.167826_bb0115","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1038\/nrc1647","article-title":"The role of focal-adhesion kinase in cancer - a new therapeutic opportunity","volume":"5","author":"McLean","year":"2005","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.bbadis.2025.167826_bb0120","doi-asserted-by":"crossref","first-page":"3526","DOI":"10.1158\/1078-0432.CCR-09-1834","article-title":"Advances in targeting SRC in the treatment of breast cancer and other solid malignancies","volume":"16","author":"Mayer","year":"2010","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.bbadis.2025.167826_bb0125","doi-asserted-by":"crossref","first-page":"14382","DOI":"10.1021\/acs.jmedchem.0c01248","article-title":"Progress in the development of small molecular inhibitors of focal adhesion kinase (FAK)","volume":"63","author":"Lu","year":"2020","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bbadis.2025.167826_bb0130","doi-asserted-by":"crossref","first-page":"3510","DOI":"10.1111\/febs.15011","article-title":"Targeting the complexity of Src signalling in the tumour microenvironment of pancreatic cancer: from mechanism to therapy","volume":"286","author":"Parkin","year":"2019","journal-title":"FEBS J."},{"key":"10.1016\/j.bbadis.2025.167826_bb0135","article-title":"Molecular basis of LH action on breast cancer cell migration and invasion via kinase and scaffold proteins","volume":"8","author":"Mondaca","year":"2020","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.bbadis.2025.167826_bb0140","doi-asserted-by":"crossref","first-page":"1846","DOI":"10.1093\/bioinformatics\/btm254","article-title":"GEOquery: a bridge between the Gene Expression Omnibus (GEO) and BioConductor","volume":"23","author":"Davis","year":"2007","journal-title":"Bioinformatics"},{"key":"10.1016\/j.bbadis.2025.167826_bb0145","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1093\/biostatistics\/kxj037","article-title":"Adjusting batch effects in microarray expression data using empirical Bayes methods","volume":"8","author":"Johnson","year":"2007","journal-title":"Biostatistics"},{"key":"10.1016\/j.bbadis.2025.167826_bb0150","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1093\/bioinformatics\/bts034","article-title":"The sva package for removing batch effects and other unwanted variation in high-throughput experiments","volume":"28","author":"Leek","year":"2012","journal-title":"Bioinformatics"},{"key":"10.1016\/j.bbadis.2025.167826_bb0155","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22052622","article-title":"TNMplot.com: a web tool for the comparison of gene expression in normal, tumor and metastatic tissues","volume":"22","author":"Bartha","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbadis.2025.167826_bb0160","doi-asserted-by":"crossref","first-page":"4101","DOI":"10.1016\/j.csbj.2021.07.014","article-title":"Survival analysis across the entire transcriptome identifies biomarkers with the highest prognostic power in breast cancer","volume":"19","author":"Gyorffy","year":"2021","journal-title":"Comput. Struct. Biotechnol. J."},{"key":"10.1016\/j.bbadis.2025.167826_bb0165","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1002\/jcc.20945","article-title":"CHARMM-GUI: a web-based graphical user interface for CHARMM","volume":"29","author":"Jo","year":"2008","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.bbadis.2025.167826_bb0170","first-page":"489","article-title":"Modulation of fibronectin expression and proteolytic activity associated with the invasive and metastatic phenotype in two new murine mammary tumor cell lines","volume":"11","author":"Urtreger","year":"1997","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.bbadis.2025.167826_bb0175","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S0303-7207(01)00698-0","article-title":"Transgenic and knockout mouse models for the study of luteinizing hormone and luteinizing hormone receptor function","volume":"187","author":"Huhtaniemi","year":"2002","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.bbadis.2025.167826_bb0180","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.mce.2006.08.016","article-title":"Novel biological and possible applicable roles of LH\/hCG receptor","volume":"269","author":"Ziecik","year":"2007","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.bbadis.2025.167826_bb0185","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1210\/rp.58.1.343","article-title":"Consequences of elevated luteinizing hormone on diverse physiological systems: use of the LHbetaCTP transgenic mouse as a model of ovarian hyperstimulation-induced pathophysiology","volume":"58","author":"Mann","year":"2003","journal-title":"Recent Prog. Horm. Res."},{"key":"10.1016\/j.bbadis.2025.167826_bb0190","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.mce.2010.04.028","article-title":"Are gonadotrophins tumorigenic\u2014a critical review of clinical and experimental data","volume":"329","author":"Huhtaniemi","year":"2010","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.bbadis.2025.167826_bb0195","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1007\/s00432-008-0458-3","article-title":"Beta-hCG\/LH receptor (b-HCG\/LH-R) expression is increased in invasive versus preinvasive breast cancer: implications for breast carcinogenesis?","volume":"135","author":"Hudelist","year":"2009","journal-title":"J. Cancer Res. Clin. Oncol."},{"issue":"Suppl. 1","key":"10.1016\/j.bbadis.2025.167826_bb0200","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1159\/000055283","article-title":"Gonadotropins stimulate growth of MCF-7 human breast cancer cells by promoting intracellular conversion of adrenal androgens to estrogens","volume":"59","author":"Tanaka","year":"2000","journal-title":"Oncology"},{"key":"10.1016\/j.bbadis.2025.167826_bb0205","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1021\/acs.jcim.2c01444","article-title":"Analysis of protein folding simulation with moving root mean square deviation","volume":"63","author":"Maruyama","year":"2023","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.bbadis.2025.167826_bb0210","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.biochi.2019.07.025","article-title":"In silico prediction of protein flexibility with local structure approach","volume":"165","author":"Narwani","year":"2019","journal-title":"Biochimie"},{"key":"10.1016\/j.bbadis.2025.167826_bb0215","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.ijbiomac.2020.02.084","article-title":"The binding mechanism of nitroreductase fluorescent probe: active pocket deformation and intramolecular hydrogen bonds","volume":"150","author":"Zhu","year":"2020","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.bbadis.2025.167826_bb0220","doi-asserted-by":"crossref","DOI":"10.1016\/j.molliq.2022.118901","article-title":"Molecular dynamics simulation approach for discovering potential inhibitors against SARS-CoV-2: a structural review","volume":"354","author":"Ghahremanian","year":"2022","journal-title":"J. Mol. Liq."},{"key":"10.1016\/j.bbadis.2025.167826_bb0225","series-title":"Computer-Aided Drug Design","first-page":"133","article-title":"Molecular dynamics simulation of protein and protein\u2013ligand complexes","author":"Shukla","year":"2020"},{"key":"10.1016\/j.bbadis.2025.167826_bb0230","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1007\/s10930-020-09953-6","article-title":"Structure-based identification of potential drugs against FmtA of Staphylococcus aureus: virtual screening, molecular dynamics, MM-GBSA, and QM\/MM","volume":"40","author":"Dalal","year":"2021","journal-title":"Protein J."},{"key":"10.1016\/j.bbadis.2025.167826_bb0235","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1530\/eje.0.1460001","article-title":"Biology of the gonadotropin-releasing hormone system in gynecological cancers","volume":"146","author":"Grundker","year":"2002","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.bbadis.2025.167826_bb0240","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1186\/1471-2407-12-550","article-title":"Gonadotropin-releasing hormone receptor activates GTPase RhoA and inhibits cell invasion in the breast cancer cell line MDA-MB-231","volume":"12","author":"Aguilar-Rojas","year":"2012","journal-title":"BMC Cancer"},{"key":"10.1016\/j.bbadis.2025.167826_bb0245","first-page":"1481","article-title":"Targeted chemotherapy for triple-negative breast cancers via LHRH receptor","volume":"25","author":"Fost","year":"2011","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.bbadis.2025.167826_bb0250","doi-asserted-by":"crossref","first-page":"2713","DOI":"10.3892\/ijo.2016.3491","article-title":"Invasion and increased expression of S100A4 and CYR61 in mesenchymal transformed breast cancer cells is downregulated by GnRH","volume":"48","author":"Grundker","year":"2016","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.bbadis.2025.167826_bb0255","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/0303-7207(94)90196-1","article-title":"The nucleotide sequences of human GnRH receptors in breast and ovarian tumors are identical with that found in pituitary","volume":"106","author":"Kakar","year":"1994","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.bbadis.2025.167826_bb0260","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1002\/path.1691","article-title":"Molecular evolution of breast cancer","volume":"205","author":"Simpson","year":"2005","journal-title":"J. Pathol."},{"key":"10.1016\/j.bbadis.2025.167826_bb0265","doi-asserted-by":"crossref","DOI":"10.3389\/fgene.2020.553587","article-title":"Classifying breast cancer molecular subtypes by using deep clustering approach","volume":"11","author":"Rohani","year":"2020","journal-title":"Front. Genet."},{"key":"10.1016\/j.bbadis.2025.167826_bb0270","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1200\/JCO.2008.18.1370","article-title":"Supervised risk predictor of breast cancer based on intrinsic subtypes","volume":"27","author":"Parker","year":"2009","journal-title":"J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol."},{"key":"10.1016\/j.bbadis.2025.167826_bb0275","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1186\/1471-2164-7-127","article-title":"Distinct molecular mechanisms underlying clinically relevant subtypes of breast cancer: gene expression analyses across three different platforms","volume":"7","author":"Sorlie","year":"2006","journal-title":"BMC Genomics"},{"key":"10.1016\/j.bbadis.2025.167826_bb0280","doi-asserted-by":"crossref","first-page":"4038","DOI":"10.1200\/JCO.2009.27.4290","article-title":"Influence of sex hormones on cancer progression","volume":"28","author":"Folkerd","year":"2010","journal-title":"J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol."},{"key":"10.1016\/j.bbadis.2025.167826_bb0285","doi-asserted-by":"crossref","DOI":"10.3390\/cells10020437","article-title":"Role of gonadotropin-releasing hormone (GnRH) in ovarian cancer","volume":"10","author":"Grundker","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.bbadis.2025.167826_bb0290","article-title":"Gonadotropin-releasing hormone receptor inhibits triple-negative breast cancer proliferation and metastasis","volume":"50","author":"Chen","year":"2022","journal-title":"J. Int. Med. Res."},{"key":"10.1016\/j.bbadis.2025.167826_bb0295","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.gendis.2018.05.001","article-title":"Breast cancer development and progression: risk factors, cancer stem cells, signaling pathways, genomics, and molecular pathogenesis","volume":"5","author":"Feng","year":"2018","journal-title":"Genes Dis."},{"key":"10.1016\/j.bbadis.2025.167826_bb0300","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1186\/bcr932","article-title":"The changing global patterns of female breast cancer incidence and mortality","volume":"6","author":"Bray","year":"2004","journal-title":"Breast Cancer Res."},{"key":"10.1016\/j.bbadis.2025.167826_bb0305","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1023\/A:1020528722842","article-title":"Elevated luteinizing hormone in serum, breast cancer tissue, and normal breast tissue from breast cancer patients","volume":"76","author":"Silva","year":"2002","journal-title":"Breast Cancer Res. Treat."},{"key":"10.1016\/j.bbadis.2025.167826_bb0310","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0303-7207(03)00155-2","article-title":"The luteinizing hormone receptor: influence of buffer composition on ligand binding and signaling of wild type and mutant receptors","volume":"204","author":"Angelova","year":"2003","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.bbadis.2025.167826_bb0315","first-page":"1873","article-title":"Luteinizing hormone facilitates angiogenesis in ovarian epithelial tumor cells and metformin inhibits the effect through the mTOR signaling pathway","volume":"27","author":"Liao","year":"2012","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.bbadis.2025.167826_bb0320","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1210\/jcem.87.3.8437","article-title":"Expression of gonadotropin-releasing hormone II (GnRH-II) receptor in human endometrial and ovarian cancer cells and effects of GnRH-II on tumor cell proliferation","volume":"87","author":"Grundker","year":"2002","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.bbadis.2025.167826_bb0325","first-page":"857","article-title":"Luteinizing hormone\/human chorionic gonadotropin receptors in breast cancer","volume":"57","author":"Meduri","year":"1997","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbadis.2025.167826_bb0330","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1038\/s12276-020-0447-4","article-title":"Targeting focal adhesion kinase in cancer cells and the tumor microenvironment","volume":"52","author":"Murphy","year":"2020","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.bbadis.2025.167826_bb0335","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s41231-023-00135-x","article-title":"Expression of HIF-1\u03b1 and markers of angiogenesis and metabolic adaptation in molecular subtypes of breast cancer","volume":"8","author":"Farooq","year":"2023","journal-title":"Transl. Med. Commun."},{"key":"10.1016\/j.bbadis.2025.167826_bb0340","doi-asserted-by":"crossref","DOI":"10.3390\/cells7080089","article-title":"New insights into the occurrence of matrix metalloproteases \u22122 and \u22129 in a cohort of breast cancer patients and proteomic correlations","volume":"7","author":"Di Cara","year":"2018","journal-title":"Cells"},{"key":"10.1016\/j.bbadis.2025.167826_bb0345","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1186\/s12885-021-07860-2","article-title":"Prognostic values of tumoral MMP2 and MMP9 overexpression in breast cancer: a systematic review and meta-analysis","volume":"21","author":"Jiang","year":"2021","journal-title":"BMC Cancer"},{"key":"10.1016\/j.bbadis.2025.167826_bb0350","series-title":"Biomedical Papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia","first-page":"272","article-title":"Circulating tumor cells and serum levels of MMP-2, MMP-9 and VEGF as markers of the metastatic process in patients with high risk of metastatic progression","volume":"vol. 161","author":"Skerenova","year":"2017"},{"key":"10.1016\/j.bbadis.2025.167826_bb0355","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.3389\/fonc.2019.01370","article-title":"Role of matrix metalloproteinases in angiogenesis and cancer","volume":"9","author":"Quintero-Fabian","year":"2019","journal-title":"Front. Oncol."},{"key":"10.1016\/j.bbadis.2025.167826_bb0360","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1038\/nature18324","article-title":"Allosteric coupling from G protein to the agonist-binding pocket in GPCRs","volume":"535","author":"DeVree","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.bbadis.2025.167826_bb0365","doi-asserted-by":"crossref","first-page":"6136","DOI":"10.2174\/0929867326666190712165444","article-title":"Gonadotropin-releasing hormone and GnRH receptor: structure, function and drug development","volume":"27","author":"Tzoupis","year":"2020","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.bbadis.2025.167826_bb0370","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1124\/jpet.301.1.95","article-title":"Pharmacological profile of a new, potent, and long-acting gonadotropin-releasing hormone antagonist: degarelix","volume":"301","author":"Broqua","year":"2002","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.bbadis.2025.167826_bb0375","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1124\/jpet.106.112326","article-title":"Rapid suppression of plasma testosterone levels and tumor growth in the dunning rat model treated with degarelix, a new gonadotropin-releasing hormone antagonist","volume":"320","author":"Princivalle","year":"2007","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.bbadis.2025.167826_bb0380","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1517\/17425255.2015.1085506","article-title":"Pharmacokinetic and pharmacodynamic profile of degarelix for prostate cancer","volume":"11","author":"Klotz","year":"2015","journal-title":"Expert Opin. Drug Metab. Toxicol."},{"key":"10.1016\/j.bbadis.2025.167826_bb0385","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1007\/s00345-019-02937-x","article-title":"Metabolic changes with degarelix vs leuprolide plus bicalutamide in patients with prostate cancer: a randomized clinical study","volume":"38","author":"Sawazaki","year":"2020","journal-title":"World. J. Urol."},{"key":"10.1016\/j.bbadis.2025.167826_bb0390","doi-asserted-by":"crossref","first-page":"2509","DOI":"10.1200\/JCO.2006.08.8534","article-title":"Leuprorelin acetate every-3-months depot versus cyclophosphamide, methotrexate, and fluorouracil as adjuvant treatment in premenopausal patients with node-positive breast cancer: the TABLE study","volume":"25","author":"Schmid","year":"2007","journal-title":"J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol."},{"key":"10.1016\/j.bbadis.2025.167826_bb0395","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1007\/s12282-015-0593-z","article-title":"A randomized controlled study evaluating safety and efficacy of leuprorelin acetate every-3-months depot for 2 versus 3 or more years with tamoxifen for 5 years as adjuvant treatment in premenopausal patients with endocrine-responsive breast cancer","volume":"23","author":"Shiba","year":"2016","journal-title":"Breast Cancer"},{"key":"10.1016\/j.bbadis.2025.167826_bb0400","doi-asserted-by":"crossref","DOI":"10.3390\/cancers12061489","article-title":"c-Src and EGFR inhibition in molecular cancer therapy: what else can we improve?","volume":"12","author":"Belli","year":"2020","journal-title":"Cancers"},{"key":"10.1016\/j.bbadis.2025.167826_bb0405","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23031726","article-title":"FAK in Cancer: from mechanisms to therapeutic strategies","volume":"23","author":"Chuang","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbadis.2025.167826_bb0410","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1038\/modpathol.3800424","article-title":"High focal adhesion kinase expression in invasive breast carcinomas is associated with an aggressive phenotype","volume":"18","author":"Lark","year":"2005","journal-title":"Mod. Pathol."},{"key":"10.1016\/j.bbadis.2025.167826_bb0415","series-title":"Src Family Kinases as Therapeutic Targets in Advanced Solid Tumors: What We Have Learned so Far","volume":"vol. 12","author":"Martellucci","year":"2020"},{"key":"10.1016\/j.bbadis.2025.167826_bb0420","doi-asserted-by":"crossref","DOI":"10.3390\/cells11192988","article-title":"Combination treatment of retinoic acid plus focal adhesion kinase inhibitor prevents tumor growth and breast cancer cell metastasis","volume":"11","author":"Castro-Guijarro","year":"2022","journal-title":"Cells"},{"key":"10.1016\/j.bbadis.2025.167826_bb0425","doi-asserted-by":"crossref","first-page":"769","DOI":"10.3748\/wjg.v19.i5.769","article-title":"Degarelix as a new antiangiogenic agent for metastatic colon cancer?","volume":"19","author":"Ghiringhelli","year":"2013","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.bbadis.2025.167826_bb0430","article-title":"Effects of docetaxel plus degarelix on quality of life and vascular endothelial growth factor in patients with prostate cancer","volume":"2022","author":"Li","year":"2022","journal-title":"J. Oncol."},{"key":"10.1016\/j.bbadis.2025.167826_bb0435","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1093\/carcin\/bgs274","article-title":"Sonic hedgehog signaling pathway induces cell migration and invasion through focal adhesion kinase\/AKT signaling-mediated activation of matrix metalloproteinase (MMP)-2 and MMP-9 in liver cancer","volume":"34","author":"Chen","year":"2012","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.bbadis.2025.167826_bb0440","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1530\/EC-19-0442","article-title":"Leptin induces cell migration and invasion in a FAK-Src-dependent manner in breast cancer cells","volume":"8","author":"Juarez-Cruz","year":"2019","journal-title":"Endocr. Connect."}],"container-title":["Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0925443925001711?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0925443925001711?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,10]],"date-time":"2025-06-10T12:35:01Z","timestamp":1749558901000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0925443925001711"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":88,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["S0925443925001711"],"URL":"https:\/\/doi.org\/10.1016\/j.bbadis.2025.167826","relation":{},"ISSN":["0925-4439"],"issn-type":[{"value":"0925-4439","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Therapeutic potential of GNRHR analogs and SRC\/FAK inhibitors to counteract tumor growth and metastasis in breast cancer","name":"articletitle","label":"Article Title"},{"value":"Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbadis.2025.167826","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"167826"}}